128 related articles for article (PubMed ID: 16247666)
1. Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.
Kurosaka S; Irie A; Mizoguchi H; Okuno N; Iwabuchi K; Baba S
Int J Clin Oncol; 2005 Oct; 10(5):362-5. PubMed ID: 16247666
[TBL] [Abstract][Full Text] [Related]
2. Mesonephric adenocarcinoma of the urinary bladder: a case report.
Honda N; Yamada Y; Nanaura H; Fukatsu H; Nonomura H; Hatano Y
Hinyokika Kiyo; 2000 Jan; 46(1):27-31. PubMed ID: 10723661
[TBL] [Abstract][Full Text] [Related]
3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
4. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall.
Poulsen AL; Horn T; Steven K
J Urol; 1998 Dec; 160(6 Pt 1):2015-9; discussion 2020. PubMed ID: 9817313
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
6. Clear cell adenocarcinoma of the bladder in a male patient: clinicopathologic analysis of a case.
Signori G; Tonini G; Aulenti V; Taher B; Rad FK; Tosana M; Ungari M; Zorzi F
Urol Int; 2003; 71(2):228-30. PubMed ID: 12890970
[TBL] [Abstract][Full Text] [Related]
7. Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up.
Kaouk JH; Goel RK; White MA; White WM; Autorino R; Haber GP; Campbell SC
Urology; 2010 Oct; 76(4):857-61. PubMed ID: 20646750
[TBL] [Abstract][Full Text] [Related]
8. [A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies].
Matsumoto S; Nishioka T; Akiyama T; Park YC; Kurita T; Ishikawa Y
Hinyokika Kiyo; 2001 Jan; 47(1):43-6. PubMed ID: 11235221
[TBL] [Abstract][Full Text] [Related]
9. Perioperative Chemotherapy in Advanced Bladder Cancer - Part II: Adjuvant Treatment.
Otto T; Goebell PJ; Rübben H
Onkologie; 2003 Oct; 26(5):484-8. PubMed ID: 14605467
[TBL] [Abstract][Full Text] [Related]
10. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Kojima Y; Yamada Y; Kamisawa H; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2006 Aug; 13(8):1123-5. PubMed ID: 16903943
[TBL] [Abstract][Full Text] [Related]
11. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
[TBL] [Abstract][Full Text] [Related]
12. Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
Kasahara K; Inoue K; Shuin T
Int J Urol; 2001 Mar; 8(3):133-6. PubMed ID: 11260340
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Urachal Carcinoma Treated by TS-1/CDDP as Adjuvant Chemotherapy].
Inoue K; Shimada M; Saito K; Ogawa Y; Matsubara E; Matsumoto Y; Keiichiro H
Hinyokika Kiyo; 2015 Nov; 61(11):441-3. PubMed ID: 26699888
[TBL] [Abstract][Full Text] [Related]
14. [Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty].
Kono Y; Terada N; Takashima Y; Hikami K; Hida T; Goto S; Sunada T; Okada Y; Shibasaki N; Negoro H; Kobayashi T; Yamasaki T; Matsui Y; Inoue T; Kamba T; Ogawa O
Hinyokika Kiyo; 2016 Jan; 62(1):33-7. PubMed ID: 26932334
[TBL] [Abstract][Full Text] [Related]
15. Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
Neuzillet Y; Lebret T; Molinie V; Yonneau L; Herve JM; Theodore C; Botto H
BJU Int; 2012 Dec; 110(11):1736-41. PubMed ID: 22998125
[TBL] [Abstract][Full Text] [Related]
16. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
18. [Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy].
Leissner J; Allhoff EP; Hohenfellner R; Wolf HK
Zentralbl Chir; 2002 Apr; 127(4):315-21. PubMed ID: 12085284
[TBL] [Abstract][Full Text] [Related]
19. Pathologic evaluation of radical cystectomy specimens: a cooperative group report.
Herr HW; Faulkner JR; Grossman HB; Crawford ED
Cancer; 2004 Jun; 100(11):2470-5. PubMed ID: 15160354
[TBL] [Abstract][Full Text] [Related]
20. [Signet ring cell carcinoma of the urinary bladder: a case report].
Ishimura H; Kudoh S; Yoneyama T; Kajihara S; Koie T; Suzuki T
Hinyokika Kiyo; 2004 Feb; 50(2):87-9. PubMed ID: 15101162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
